Search
Farr Takes Helm of Heart Failure/LVAD/Transplant Section | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/farr-takes-helm-heart-failure-lvad-transplant-section/
Nationally recognized cardiologist Maryjane Farr, M.D., has joined UT Southwestern as Section Chief of Heart Failure, VAD, and Transplant. Previously, she directed the Adult Heart Transplant Program at the Columbia University Irving Medical Center.
Cardiology at UT Southwestern: A Year of Achievement | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/cardiology-at-ut-southwestern-a-year-of-achievement/
Nationally recognized cardiologist Maryjane Farr, M.D., has joined UT Southwestern as Section Chief of Heart Failure, VAD, and Transplant. Previously, she directed the Adult Heart Transplant Program at the Columbia University Irving Medical Center.
Growing in Breadth and Depth | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/growing-in-breadth-and-depth/
UT Southwestern's Dr. John Warner introduces the 2021 Physician Update — highlights from UTSW's research presented at the annual AHA Scientific Sessions.
Cardiovascular Health in Women | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/cardiovascular-health-in-women/
UT Southwestern's Ann Marie Navar, M.D., Ph.D., provided an overview of risk factors for cardiovascular disease in women at the 2021 AHA Scientific Sessions.
SGLT2 Inhibition in Acute Decompensated Heart Failure: Another Win for this Remarkable Class of Medications | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/sglt2-inhibition-in-acute-decompensated-heart-failure/
UT Southwestern's Dr. Mark Drazner highlights discussion focused on the EMPULSE trial at the 2021 AHA Scientific Sessions.
Polypill Therapy and Risk of Adverse Cardiovascular Events and Mortality | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/polypill-therapy-and-risk-of-adverse-cardiovascular-events-and-mortality/
UT Southwestern's Ambarish Pandey, M.D., and Shreya Rao, M.D., presented on the impact of polypills on cardiovascular outcomes and risk factors at #AHA21.
A Blurred Line: What’s the Distinction Between Primary and Secondary Prevention Today? | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/a-blurred-line-whats-the-distinction-between-primary-and-secondary-prevention-today/
UT Southwestern's Dr. Amit Khera summarizes the distinction between primary and secondary prevention of ASCVD in a session at the 2021 AHA Scientific Sessions.
High-Sensitivity Troponin and Type 2 MI: Patient Characteristics and Impact on the Health System | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/high-sensitivity-troponin-and-type-2-mi-patient-characteristics-and-impact-on-the-health-system/
During a session on Troponin Testing in Acute Coronary Syndrome at #AHA21, Dr. Rebecca Vigen discussed UT Southwestern's experience with the protocol.
Rapid-Fire Results from AHA Research on COVID-19 | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/rapid-fire-results-from-aha-research-on-covid-19/
UT Southwestern's Dr. James de Lemos highlights research on COVID-19 and cardiovascular disease that was presented at the 2021 AHA Scientific Sessions.
Circulation Symposium at #AHA21 | Physician Update 2021 | UT Southwestern Medical Center
https://utswmed.org/heart/physician-update/2021/circulation-symposium-at-aha21/
UT Southwestern's Joseph A. Hill, M.D., Ph.D., summarizes the Circulation symposium at the 2021 AHA Scientific Sessions.